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Abstract
Background: Translationally Controlled Tumor Protein (TCTP) found in nasal lavage fluids of allergic patients was named
IgE-dependent histamine-releasing factor (HRF). Human recombinant HRF (HrHRF) has been recently reported to be much
less effective than HRF produced from activated mononuclear cells (HRFmn).
Methods and Findings: We found that only NH2-terminal truncated, but not C-terminal truncated, TCTP shows cytokine
releasing activity compared to full-length TCTP. Interestingly, only NH2-terminal truncated TCTP, unlike full-length TCTP,
forms dimers through intermolecular disulfide bonds. We tested the activity of dimerized full-length TCTP generated by
fusing it to rabbit Fc region. The untruncated-full length protein (Fc-HrTCTP) was more active than HrTCTP in BEAS-2B cells,
suggesting that dimerization of TCTP, rather than truncation, is essential for the activation of TCTP in allergic responses. We
used confocal microscopy to evaluate the affinity of TCTPs to its putative receptor. We detected stronger fluorescence in the
plasma membrane of BEAS-2B cells incubated with Del-N11TCTP than those incubated with rat recombinant TCTP (RrTCTP).
Allergenic activity of Del-N11TCTP prompted us to see whether the NH2-terminal truncated TCTP can induce allergic airway
inflammation in vivo. While RrTCTP had no influence on airway inflammation, Del-N11TCTP increased goblet cell hyperplasia
in both lung and rhinal cavity. The dimerized protein was found in sera from allergic patients, and bronchoalveolar lavage
fluids from airway inflamed mice.
Conclusions: Dimerization of TCTP seems to be essential for its cytokine-like activity. Our study has potential to enhance the
understanding of pathogenesis of allergic disease and provide a target for allergic drug development.
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Introduction
Translationally controlled tumor protein (TCTP), also variously
known as IgE-dependent histamine-releasing factor (HRF) [1],
p23/p21 [2,3], and fortilin [4], is distributed in all normal cell
types. It exhibits a high degree of homology among various
species, suggesting that TCTP may play an essential role in
cellular processes [5]. Many studies demonstrated that TCTP is a
multifunctional protein [6]. TCTP was reported to be involved,
extracellularly, in human allergic response as an HRF [1] and
intracellularly, as a microtubule-stabilizing protein [7], as an
antiapoptotic protein [4], and in protein synthesis as a guanine
nucleotide dissociation inhibitor [8]. We reported recently that
TCTP also acts as a suppressor of Na,K-ATPase [9].
Extracellularly TCTP appears outside of macrophages [10] and
activated mononuclear cells [11], in bronchoalveolar lavage fluids
(BALF) from patients with eosinophilic pneumonia and asthma
[12], in nasal washings [13], and in skin blister fluids during the
late allergic reaction [14]. Human recombinant HRF (HrHRF)
directly stimulates the secretion of histamine, IL-4, and IL-13 from
a subpopulation of basophils, and also enhances their secretion
from all IgE-bearing basophils activated by anti-IgE Ab [15].
HrHRF stimulates the secretions of IL-8 and GM-CSF in primary
cultures of human bronchial epithelial cells and human bronchial
epithelial cell line, BEAS-2B [12].
HrHRF has been recently reported to be much less effective
than HRF produced from activated mononuclear cells (HRFmn).
Also, presence of HRFmn could not be demonstrated in serum
when an HrHRF-specific ELISA assay was used [16]. These
findings suggest that extracellular TCTP exhibiting cytokine-like
activity in vivo might be a modified form of intracellular TCTP.
We hypothesized that the observed differences in the activity of
HRFmn and HrHRF might arise from modifications occurring
in TCTP in the allergic environment. In this study, we tested this
hypothesis by characterizing the active forms of TCTP and
examining the conformational differences between the modified
PLoS ONE | www.plosone.org 1 July 2009 | Volume 4 | Issue 7 | e6464and the unmodified forms of TCTP. We also investigated
whether the modified form of TCTP could induce allergic
inflammation in vivo and whether it is present in sera from
allergic patients and in bronchoalveolar lavage fluids from airway
inflamed mice.
Results
NH2-terminal truncated RrTCTP increases IL-8 and GM-
CSF secretion from BEAS-2B cells
Since endogenous proteases from neutrophils [17] and mast cells
[18] are present in sites of inflammation, we wondered if TCTP
acquires its cytokine-like activity following partial proteolysis by
these proteases. To answerthis question,we designed fiveratTCTP
constructs including a rat recombinant TCTP (RrTCTP) construct
andfour deletionconstructs:Del-N11TCTP(residues11–172), Del-
N35TCTP (residues 35–172), Del-C112TCTP (residues 1–112),
and Del-N39C110TCTP (residues 39–110) (Figure 1A). RrTCTP
and the RrTCTP deletion derivatives were tested for their ability to
stimulate the secretion of IL-8 [12] from BEAS-2B bronchial
epithelial cells. When BEAS-2B cells were treated with RrTCTP,
IL-8 release was stimulated in a dose- and time-dependent fashion
(Figure 1, A and B). Under the same experimental condition, Del-
N11TCTP and Del-N35TCTP stimulated IL-8 release about 4–9
fold better than RrTCTP; Del-C112TCTP stimulated IL-release at
about the same level as RrTCTP; Del-N39C110TCTP did not
show any stimulatory activity, and this may be due to an alteration
in its tertiary structure by excessive deletion. The level of GM-CSF
secretion was somewhat lower than that of IL-8 secretion in BEAS-
2B cells. We could measure GM-CSF secretion by Del-N11TCTP
and Del-N35TCTP derivatives, but not by RrTCTP (Figure 1C).
These results suggest that NH2-terminal truncation increases the
cytokine-like activity of RrTCTP.
NH2-terminal truncated RrTCTP enhances allergic
response in T cells
TCTP is known to inhibit the release of IL-2 in human
peripheral blood T cells and Jurkat T cells [19]. Because Del-
N11TCTP and Del-N35TCTP showed increased cytokine
releasing activity in BEAS-2B cells, we further evaluated their
activity in T cells. Jurkat T cells produce IL-2 when stimulated by
PMA/calcium ionophore [20]. First, we examined the activation
profile of our cells by PMA/ionomycin. IL-2 secretion was
stimulated in a dose-dependent manner between 50–500 mm/ml
of ionomycin in the presence of PMA (data not shown), and we
used 125 mm/ml of ionomycin in additional experiments. Cells
were preincubated in growth media with or without 10 mm/ml of
RrTCTP, Del-N11TCTP, or Del-N35TCTP for 4 h, followed by
20 h incubation with PMA/ionomycin (Figure 2A). The inhibition
pattern of IL-2 release correlated with activation pattern of IL-8
release: Del-N11TCTP was the most active. While RrTCTP
suppressed 26.865.7% of IL-2 secretion, Del-N11TCTP and Del-
N35TCTP suppressed 57.6612.4% and 46.569.0% of IL-2
secretion in Jurkat T cells stimulated with PMA/ionomycin,
respectively.
We also examined the effect of TCTP on cytokine production in
murine CD4
+ TH cells upon TCR stimulation. In accordance with
previous findings, Del-N11TCTP, but not RrTCTP, substantially
suppressed IL-2 production in CD4
+ TH cells stimulated with anti-
CD3 and anti-CD28 antibodies for 48 h (Figure 2B). Furthermore,
the level of IL-4 increased by PMA and ionomycin was augmented
in the presence of Del-N11TCTP, but not RrTCTP (Figure 2D),
while IFN-c was not changed by either RrTCTP or Del-N11TCTP
(Figure 2C). Also, intracellular cytokine staining revealed decreased
IL-2 and increased IL-4 secretion by Del-N11TCTP (Figure 2E).
IFN-c and IL-4 are the main cytokines in TH1 and TH2 cells,
respectively [21]. Cross-inhibition of TH cell differentiation by IFN-
c and IL-4 is well known [22]. Abnormal activation of TH2 cells
causes allergic disorders [23]. When the cells differentiate into IL-4-
producing TH2 cells, IL-4 production was significantly increased by
Del-N11TCTP, but not by RrTCTP (Figure 2F). These results
suggest that Del-N11TCTP, but not RrTCTP increases allergic
cytokine IL-4 in CD4
+ TH cells, thereby promoting allergenic
activity.
NH2-terminal truncated RrTCTP forms intermolecular
disulfide bridge
To test whether the higher activity of the truncated protein is
due to altered conformations not present in the full-length protein,
we compared the mobility of these proteins in reducing and non-
reducing SDS-polyacrylamide gels (Figure 3, A and B). We found
that NH2-terminus containing proteins were all detected at
molecular sizes corresponding to a monomer, regardless of the
presence or absence of b-mercaptoethanol (b-ME), while the NH2-
terminal truncated forms showed mobility shifts corresponding to
a dimer under non-reducing conditions, which suggests that NH2-
terminal truncated proteins form dimers probably through
intermolecular disulfide bonds.
TCTP contains two cysteine residues, Cys
28 and Cys
172.T o
identify the residue forming disulfide bonds, we analyzed three
mutants, Del-N11TCTP-C28S, Del-N11TCTP-C172S, and Del-
N35TCTP-C172S by SDS-PAGE (Figure 3C). Under non-
reducing conditions, Del-N11TCTP, Del-N35TCTP, and Del-
N11TCTP-C28S electrophoresed at the apparent molecular
weight corresponding to the dimer. Del-N11TCTP-C28S also
showed an additional minor band corresponding to the monomer.
Del-N11TCTP-C172S and Del-N35TCTP-C172S were detected
at positions corresponding to the monomer, with Del-N11TCTP-
C172S also showing an additional minor band corresponding to
the dimer. These results suggest that although both Cys
28 and
Cys
172 seem to be involved in the formation of intermolecular
disulfide bond, Cys
172 is the main site of dimerization.
There are several reports that TCTP homologues form dimeric
structures [24–26]. To elucidate the oligomeric structure of TCTP,
the apparent molecular weights of Del-N35TCTP and Del-
N35TCTP-C172S were determined using size exclusion column
chromatography (Figure 3D). Del-N35TCTP showed two peaks, a
major peak of approximately 45 kDa corresponding to the dimeric
form and a minor peak of about 29 kDa corresponding to the
monomeric form (Figure 3D-i). Del-N35TCTP-C172S also showed
twopeaks,butthemajorpeak correspondedto the monomeric form
(Figure 3D-ii).
We also tested whether the NH2-terminal truncated RrTCTP
can be dimerized by oxygen species such as H2O2. RrTCTP and
Del-N35TCTP were completely reduced with 20 mM DTT, and
then oxidized by increasing concentrations of H2O2 (Figure 3E).
Whereas RrTCTP showed only minimal fraction of dimers, all the
Del-N35TCTP migrated in the dimer position in non-reducing
SDS-polyacrylamide gels in the presence of H2O2. This implies
that only the NH2-terminal truncated TCTP can be modified by
reactive oxygen species at sites of inflammation.
Dimerization of RrTCTP by intermolecular disulfide bond
is critical to its activity
In order to determine whether disulfide linkages of NH2-
terminal truncated RrTCTP are critical for the cytokine-like
activity, we compared IL-8 secretions stimulated by wild-type
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N35TCTP-C172S exhibited reduced ability for IL-8 secretion
(52% and 36% of wild-type, respectively) from BEAS-2B cells,
indicating that disulfide bonds are important for the cytokine-like
activity of RrTCTP (Figure 4, A and B). Del-N11TCTP-C172S
caused more IL-8 release than Del-N35TCTP-C172S. This is
probably due to the presence of a small amount of the dimer form
of Del-N11TCTP-C172S, disulfide bonded through Cys
28.C y s
28
Figure 1. NH2-terminal truncated RrTCTPs show increased activity in BEAS-2B cells. (A) BEAS-2B cells were treated with 1 or 10 mm/ml of
RrTCTP or various RrTCTP derivatives for 48 h. The resulting IL-8 in supernatant was analyzed by ELISA (*** p,0.001, significantly different from the
NC value, n=3). (B) 10 mm/ml of RrTCTP or RrTCTP derivatives were added to BEAS-2B cells and incubated for 1, 6, or 24 h (** p,0.01, *** p,0.001,
significantly different from the NC value, n=3). (C) 10 mm/ml of RrTCTP or RrTCTP derivatives were added to BEAS-2B cells and incubated for 48 h.
The resulting GM-CSF in supernatant was analyzed by ELISA (*** p,0.001, significantly different from the NC value, n=3).
doi:10.1371/journal.pone.0006464.g001
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PLoS ONE | www.plosone.org 3 July 2009 | Volume 4 | Issue 7 | e6464Figure 2. NH2-terminal truncated RrTCTPs augment inflammatory responses in T cells. (A) Jurkat cells were incubated with 10 mm/ml of
RrTCTP or RrTCTP derivative for 4 h, and further stimulated with 10 mm/ml PMA and 125 mm/ml ionomycin for 20 h. IL-2 level in each supernatant
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PLoS ONE | www.plosone.org 4 July 2009 | Volume 4 | Issue 7 | e6464was measured by ELISA. IL-2 release by 10 mm/ml PMA and 125 mm/ml ionomycin (positive control, PC) was expressed as 100 % (* p,0.05, ** p,0.01,
*** p,0.001, significantly different from the PC value, n=3). (B-D) Isolated CD4
+ TH cells were stimulated with anti-CD3 (1 mg/ml) and anti-CD28
(1 mg/ml) antibodies for 48 h, and 0 (without protein), 2 or 10 mm/mlof RrTCTP or Del-N11TCTP for 48 h. IL-2 or IFN-c in supernatant were analyzed
by ELISA (** p,0.01, *** p,0.001, significantly different from the ‘0 (without protein)’ value). (E) Purified CD4
+ TH cells were incubated with anti-CD3
and anti-CD28 antibodies and 2 or 10 mm/ml of RrTCTP or Del-N11TCTP for 72 h, and additionally stimulated with PMA and ionomycin for 4 h. Cells
were treated with monensin for 2 h, and labeled with PE-IL-2 Ab or APC-IL-4 Ab. Cells were analyzed by FACS Calibur and CellQuest. (F) Isolated CD4
+
TH cells were differentiated into TH 2 cells in the presence of IL-4 (10 mm/ml) and anti-IFN-c (5 mg/ml) and re-stimulated. 10 mm/ml of RrTCTP or Del-
N11TCTP were added the culture media every other day. The level of IL-4 was determined using ELISA (* p,0.05, significantly different from the NC
value).
doi:10.1371/journal.pone.0006464.g002
Figure 3. NH2-terminal truncated RrTCTP forms dimer by intermolecular disulfide bond. (A) RrTCTP was boiled with or without reducing
agent and subjected to SDS-PAGE. (B) NH2-terminal or COOH-terminal truncated RrTCTPs were run in the presence or absence of b-ME on a 15% gel,
and stained with coomassie brilliant blue. (C) Del-N11HRF, Del-N35HRF, and their mutants were analysed by reducing or non-reducing 15% SDS-
PAGE. (D) Del-N35TCTP (i) and Del-N35TCTP-C172S (ii) were loaded onto Superdex 200 HR 10/30 gel filtration column (Amersham Pharmacia Biotech).
The column was equilibrated and eluted with 50 mM sodium phosphate, pH 7.0 containing 150 mM NaCl. The eluting positions were calibrated with
the molecular size marker (Sigma) and the peak positions of molecular mass standards are indicated by vertical arrow. (E) Completely reduced RrTCTP
or Del-N35TCTP were transferred to 50 mM Tris, pH 7.5, 1 mM EDTA, and then oxidized with 0.1, 1, or 10 mM H2O2. Resulting products were analysed
by reducing and non-reducing SDS-polyacrylamide gels.
doi:10.1371/journal.pone.0006464.g003
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of Del-N35TCTP that does not contain Cys
28 is slightly lower
than that of Del-N11TCTP. Interestingly, Del-N35TCTP-
C172S, which does not contain Cys
28 and Cys
172 is about two
fold more active than RrTCTP (Figure 1B). This is probably due
to the minor presence of dimer as seen in Figure 3D-ii. These
results suggest that Cys
172 may play a major role in the cross-
linking of TCTP by disulfide bond and that the enhanced
biological activity of the truncated RrTCTP may be due to the
dimerization.
Dimerization of TCTP, not truncation, is essential for the
cytokine-like activity of TCTP
To further characterize the active form of TCTP, we performed
chemical crosslinking experiments using three irreversible cross-
linkers, DMS (dimethyl suberimidate? 2HCl), BMOE (bis-
maleimidoethane), and BM(PEO)3 (1, 11-bismaleimidotriethylene
glycol). When BMOE or BM(PEO)3 was added, Del-N35TCTP
formed dimer regardless of the length of spacer arm of crosslinkers
in reducing SDS-PAGE (Figure 5A). Interestingly, a part of
RrTCTP formed an intramolecular link by these reagents. Since
only RrTCTP monomers and Del-N35TCTP dimers, but not
intermediate products, were detected in the mixture of RrTCTP
and Del-N35TCTP, it appears that Del-N35TCTP and RrTCTP
can not be cross-linked each other. To test if these proteins could
form dimers through interactions other than disulfide bond
formation, we used DMS, an irreversible crosslinker for primary
amines. RrTCTP and Del-N35TCTP did not form oligomers,
implying that Del-N35TCTP may form dimers only through
disulfide bonds. We measured the secretion of IL-8 by DTT-
treated Del-N35TCTP, BMOE or BM(PEO)3-treated RrTCTP,
and BMOE or BM(PEO)3-treated DTT-pretreated-Del-
N35TCTP (Figure 5B). Chemical crosslinkers did not influence
RrTCTP. The activity of the DTT-treated Del-N35TCTP was
71.764.4%, and the activities of crosslinked forms were
108.560.1% and 122.468.7% of that of DTT-untreated Del-
N35TCTP, respectively.
Next, we questioned if dimerization or truncation is important
for cytokine-like activity. To answer this question, it was
necessary to test the activity of dimerized full-length TCTP,
which was not formed by the chemical crosslinkers. Therefore,
we generated a dimeric form of full-length human recombinant
TCTP (HrTCTP) by fusing it to rabbit Fc region (Figure 5C).
The CH3 of Fc region can form a non-covalent homodimer
[27,28]. We analyzed rabbit Fc protein (Fc) and Fc-fused
HrTCTP by Western blotting using rabbit IgG specific antibody.
The apparent molecular weight of the Fc-fusion proteins
increased due to glycosylation at Fc region in denaturing gel
( F i g u r e5 D ) ,a n dt h ep r o t e i n sw e r ed e t e c t e da tap o s i t i o n
corresponding to the dimer in native gel (Figure 5E).T h e
untruncated-full length protein (Fc-HrTCTP) was more active
than HrTCTP in BEAS-2B cells (Figure 5F), suggesting that
dimerization of TCTP, rather than truncation, is essential for the
activation of TCTP in allergic responses.
NH2-terminal truncated RrTCTP showed increased affinity
to the putative receptor
We hypothesized that the conformational difference between
RrTCTP and NH2-terminal truncated RrTCTP may lead to
differential affinities to its receptor in plasma membrane. Although
the TCTP receptor has not been identified, binding between
TCTP and TCTP receptor has been demonstrated using FACS
analysis in several reports [29,30]. We used the confocal
microscopy to evaluate the affinity of TCTPs to the receptor
(Figure 6). When equivalent amounts (5 mM) of RrTCTP or Del-
N11TCTP were incubated with BEAS-2B cells, and stained with
rabbit anti-TCTP and rhodamine-conjugated goat anti-rabbit
antibody, we found stronger fluorescence in plasma membrane of
BEAS-2B cells incubated with Del-N11TCTP rather than with
RrTCTP. The z stack analysis showed Del-N11TCTP was
exclusively localized at the plasma membrane (bottom panel in
Figure 6).
NH2-terminal truncated RrTCTP promotes allergic airway
inflammation in mice
Allergenic activity of Del-N11TCTP prompted us to see
whether the NH2-terminal truncated TCTP can induce allergic
airway inflammation in vivo. We sensitized and challenged BALB/c
mice with either RrTCTP or Del-N11TCTP and examined the
development of allergic lung inflammation compared to sensitiza-
tion and challenge with OVA (Figure 7A). To evaluate the severity
of inflammatory response, the number of BAL cells in total BALF
was counted in a hemocytometer (Figure 7B). Total number of
immune cells in BALF was significantly increased by OVA
injection. Whereas RrTCTP injection (RrTCTP-RrTCTP) had
no effect on immune cell infiltration, Del-N11TCTP injection
(N11TCTP-N11TCTP) showed increases in total number of cells
in BALF, in particular lymphocytes and eosinophils (Figure 7, B
Figure 4. Dimerization by disulfide bond is essential for TCTP activity. (A, B) Secretion of IL-8 from BEAS-2B cells was measured after
incubation with 5 mm/ml of Del-N11TCTP, Del-N35TCTP or their mutants for 24 h (* p,0.05, **p,0.01, ***p,0.001, significantly different from their
wild-type value, n=3).
doi:10.1371/journal.pone.0006464.g004
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Del-N11TCTP (Figure 7D), reflecting the allergenic activity of
Del-N11TCTP in vivo. Because accumulation of eosinophils in
airway tissue contributes to mucus production [31], we sectioned
and stained lung and nasal mucosa with PAS. As expected, OVA
injection induced goblet cell hyperplasia in the lung and nasal
mucosa (Figure 7, E and F). While RrTCTP had no influence on
airway inflammation, Del-N11TCTP increased goblet cell hyper-
plasia in both lung and nasal mucosa, suggesting that NH2-
terminal truncated TCTP, rather than full length TCTP, is an
active form of TCTP that can induce allergic airway inflamma-
tion.
Figure 5. Dimerization of TCTP is necessary for the cytokine-like activity of TCTP. (A, B) RrTCTP and Del-N35TCTP were irreversibly cross-
linked by DMS, BMOE, or BM(PEO)3. Proteins were completely reduced with 20 mM DTT before incubating with BMOE or BM(PEO)3. Crosslinker-
treated RrTCTP, Del-N35TCTP, and their 1/2:1/2 molar mixture were analysed by reducing SDS-PAGE. And, the secretion activities of IL-8 by DTT,
BMOE, or BM(PEO)3-treated RrTCTP or Del-N35TCTP were compared using BEAS-2B cells (** p,0.01, ***p,0.001, significantly different from untreated
Del-N35TCTP or DTT-treated Del-N35TCTP value, n=3). (C) Schematic diagram of Fc-fused human recombinant TCTP (Fc-HrTCTP). (D) Fc fusion
proteins were analyzed by Western blotting with HRP conjugated anti-rabbit IgG. (E) Fc fusion proteins were analyzed using native gel. The apparent
molecular weights were confirmed by the molecular size marker (Sigma). (F) The release activities of IL-8 by indicated protein were compared in
BEAS-2B cells (** p,0.01, significantly different from Fc value, n=3).
doi:10.1371/journal.pone.0006464.g005
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PLoS ONE | www.plosone.org 7 July 2009 | Volume 4 | Issue 7 | e6464Figure 6. NH2-terminal truncated RrTCTP has strong affinity for the receptor in BEAS-2B cells. NC (without protein), RrTCTP, Del-
N11TCTP were incubated with BEAS-2B cells at 4uC, and stained with rabbit anti-TCTP and rhodamine-conjugated goat anti-rabbit antibody. Confocal
immunofluorescence (right) and corresponding DIC (left) images are presented (800X, 1600X for bottom panel). Scale bars indicate 10 mm.
doi:10.1371/journal.pone.0006464.g006
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PLoS ONE | www.plosone.org 8 July 2009 | Volume 4 | Issue 7 | e6464Figure 7. NH2-terminal truncated RrTCTP induces airway inflammation. (A) Six groups of mice were sensitized at days 0 and 14, and were
challenged at days 28–38. (B, C) Total BALF cells and leukocytes in BALF were counted using HEMAVET HV950FS (Drew Scientific Inc.) at day 40. The
eosinophils count (C) was re-displayed with small scale (* p,0.05, **p,0.01, ***p,0.001, significantly different from the Sham value, n=4–6). (D) The
IL-5 level in BALF was analyzed by mouse IL-5 ELISA kit (PIERCE) (* p,0.05, *** p,0.001, significantly different from the Sham value, n=4–6). (E, F)
Lung tissue (E) and nasal mucosa section (F) were prepared at day 40, and stained with periodic acid-Schiff (PAS) reagent. Mucus containing goblet
cells were showed as deep purple. Scale bars indicate 50 mm.
doi:10.1371/journal.pone.0006464.g007
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OVA challenge is known to stimulate the secretion of mouse
TCTP and infiltration of eosinophils in an OVA-immunized mice
model [32]. Since development of airway inflammation is
observed in OVA-OVA and N11TCTP-N11TCTP sensitiza-
tion/challenge experiments, we examined the relation between the
severity of allergy and TCTP secretion to the BALF in the same
model. Although various amounts of TCTP were found secreted
in all the groups, only the mice suffering from inflammation
showed increased TCTP secretion (Figure 8A). We also detected
dimerized TCTP in BALFs from mice with airway inflammation
(Figure 8B). Interestingly, almost all TCTP in BALF was detected
at a position corresponding to the dimer in non-reducing SDS-
PAGE.
Next, we tried to detect dimerized TCTP in serum of atopic and
atopic/asthmatic patients. We could not detect the dimerized
TCTP in serum denatured in sample buffer (50 mM Tris, pH 6.8,
2.5% SDS, 22% glycerol). We, therefore, precipitated the serum
proteins with acetone/TCA [33] and denatured them in 8 M
urea/2% CHAPS (Figure 8C). TCTP was detected in both
monomer and dimer size, and these were not single form in non-
reducing SDS-PAGE.
Figure 8. TCTP exists as dimers in allergic fluids. (A) 50ml of BALFs were analyzed by non-reducing SDS-PAGE and Western blotting. The
present figure is representing 4 results. The intensity of each band was quantified by Multi Guage software (Fujifilm). (B) The BALF from OVA-OVA
(OVA sensitized and OVA challenged, lane 1–4), and N11TCTP-N11TCTP (Del-N11TCTP sensitized and Del-N11TCTP challenged, lane 5–9) groups were
analyzed by non-reducing SDS-PAGE and Western blotting. (C) The sera from atopic (lane 1–4) or atopic/asthmatic (lane 5, 6) patients were analyzed
by non-reducing SDS-PAGE and Western blotting.
doi:10.1371/journal.pone.0006464.g008
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Our data suggest that NH2-terminal truncated RrTCTPs
potently stimulate inflammatory responses. Del-N11TCTP and
Del-N35TCTP at low concentration (1 mm/ml) could stimulate
IL-8 release, but RrTCTP at the same concentration did not
induce measurable IL-8 release. This activity was repeatedly
observed in GM-CSF, IL-2, and IL-4 release and in airway
inflamed mouse model. Thus, it would appear that some NH2-
terminal truncated forms e.g. Del-N11TCTP or Del-N35TCTP
might play a major role in allergic response in vivo. We also showed
that the dimerization of NH2-terminal truncated TCTPs via
intermolecular disulfide was a key factor to the activation of
TCTP. According to the solution structure of TCTP from
Schizosacchromyces pombe [34], the NH2-terminus and the COOH-
terminus of TCTP are packed as antiparallel b-sheets. Thus part
of the NH2-terminus may prevent disulfide bond formation. We
found truncation of at least four amino acids (residues 1–4) is
required to dimerize RrTCTP (data not shown). When the NH2-
terminus is removed, Cys
172 becomes exposed, and TCTP is able
to form intermolecular disulfide bond.
Extracellular TCTP has been identified in the culture
supernatants of the human U937 macrophage cell line [1], and
several stimulators, such as H2O2 [12], M-CSF [32], and dioxin
[35] have been found to promote the secretion of TCTP
homologues. Teshima et al. proposed that the 30 kDa protein
detected in the supernatant of OVA-elicited macrophages was
probably an N-glycosylated mouse TCTP, since this protein
treated with N-glycosidase F migrated to the same position as that
in the cytosol [32]. However, since intraperitoneal injection of
mouse recombinant TCTP that was not glycosylated could induce
eosinophil migration in OVA-immunized mice, but not in normal
mice [32], N-glycosylation may not be necessary for the cytokine-
like activity of mouse TCTP. Moreover, a recent report showed
that the secretion of human TCTP is not limited to cells that are
activated by stimulators. These human TCTPs have the same
apparent molecular weight both in the supernatants and in cell
lysates of unstimulated embryonic kidney cells (293T), hepatocytes
(HepG2), and erythroleukemia cells (K562) [36]. These findings
suggest that human TCTP may be present in normal serum
without causing any allergic syndrome and therefore, the cytokine-
like activity of TCTP homologues may be due to a modified form
that is generated in allergic environments.
MacDonald et al. showed that extracellular TCTP purified
from culture supernatants of U937 cells contains the NH2-terminal
sequence [1]. We examined TCTP secreted from U937 cells
stimulated by M-CSF as well as H2O2 and detected only
monomers (data not shown). However, we could identify TCTP
dimers in sera of allergic patients and BALF of allergic mouse,
suggesting that allergic symptoms caused by TCTP may occur
only if TCTP is modified in allergic environment. The
modification may be caused by oxidants released by neutrophils
at the site of inflammation [37], or truncation by endogenous
proteases from neutrophils [17], mast cells [18], and cytotoxic T
cells [38] or exogenous proteases originating from the house dust
mites Dermatophagoides pteronyssinus [39] and Dermatophagoides farinae
[40]. Therefore, it is possible that the reported cytokine-like
activity of TCTP might be due to the presence of a partially
cleaved TCTP. Indeed, there was a faint band of partially cleaved
RrTCTP in the absence of H2O2, and a faint band of dimer in the
presence of H2O2 (Figure 3E and 5A), suggesting that full-length
rTCTP purified from E. coli was partially digested probably by
contaminating proteases. Alternatively, other forms of active
TCTP e.g. TCTP bound by a TCTP-specific IgE [41], may exist
and the NH2-terminal deleted proteins observed in our study
might possess the active conformation fortuitously. Studies on
TCTP homologues identified from Parasites [24,42] suggest the
possibility of presence of autoantibodies. Indeed, our experiment
with Fc-HrTCTP, in which TCTP was fused to Fc region of
antibody and dimerized, suggest the possible modification of
TCTP by antibodies in vivo.
We also showed that dimerized TCTP exists in sera of atopic
and atopic/asthmatic patients and in BALFs from mice with
airway inflammation. Interestingly, the TCTP in BALF was
difficult to convert into a monomer in reducing sample buffer,
which suggests the existence of strong non-covalent bond(s). We
also detected the dimer in C172S mutant and incomplete loss of
activity of DTT-treated Del-N35TCTP, suggesting that the
dimeric form still remained after the disruption of disulfide bond
by Cys
172. Based on their observation that Brugia malayi TCTP
(BmTCTP) forms a dimer under non-reducing conditions,
whereas monomeric form is detected predominantly under
reducing conditions, Gnanasekar et al. proposed self-interaction
by Lupas coiled coil structure of residues 92–124 in BmTCTP
[24]. Therefore, it is possible that other interactions such as Lupas
coiled coil structure might be also involved in the formation of
TCTP dimer. However, our results strongly suggest that dimerized
TCTP is the active form in vivo rather than the intact monomer.
We propose that the TCTP-specific receptor can be possibly
identified using the dimer form of TCTP, and this possibility is
under investigation.
In conclusion, this study suggests that there are conformational
differences between full-length RrTCTP and NH2-terminal
truncated RrTCTP, and only the dimerized RrTCTP possesses
cytokine-like activity.
Materials and Methods
Preparation of RrTCTP, truncated TCTPs, and mutated
TCTPs
The sequences coding rat TCTP and deleted rat TCTPs
(RrTCTP, residue 1–172; Del-N11TCTP, residues 11–172; Del-
N35TCTP, residues 35–172; Del-N39C110TCTP, residues 39–
110) were amplified using the oligonucleotide primers for cloning
into the bacterial expression vector, pRSET A (Invitrogen). The
residues 1–172 was amplified using forward-CG GGATCC
(BamHI) ATG ATC ATC TAC CGG GAC- and reverse
primer-CCC AAGCTT (HindIII) ACA TTT TTC CAT CTC
TAA GCC, the residues 11–172 was amplified using forward-CG
GGATCC (BamHI) GAC GAG CTG TCC TCC GAC AT- and
reverse primer-CCC AAGCTT (HindIII) ACA TTT TTC CAT
CTC TAA, the residues 35–172 was amplified using forward-CG
GGATCC (BamHI) AGT GTC AGT AGA ACA GAG- and
reverse primer-CCC AAGCTT (HindIII) ACA TTT TTC CAT
CTC TAA, and the residues 39–110 was amplified using forward-
CG GGATCC (BamHI) ACA GAG GGT GCC ATC GA and
reverse primer-G GAATTC (EcoRI) CCT TTC TGG TTT CTG
TT.
Three mutations were introduced into the Del-N11TCTP (Del-
N11TCTP-C28S and Del-N11TCTP-C172S) and Del-N35TCTP
(Del-N35TCTP-C172S) in order to eliminate the cysteine residues
using the QuickChange Site-Directed Mutagenesis Kit (Strata-
gene). The pRSET A/Del-N11TCTP and pRSET A/Del-
N35TCTP were amplified with complimentary oligonucleotide
primers containing the mutation; for Del-N11TCTP-C28S, CG
GAC GGG CTG TCT CTG GAG GTG GA and TC CAC CTC
CAG AGA CAG CCC GTC CG, for Del-N11TCTP-C172S and
Del-N35TCTP-C172S, GAG ATG GAA AAA TCT AAG CTT
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CTC.
Escherichia coli BL21(DE3)pLysS cells transformed with the
pRSET A/TCTPs or pRSET A/mutated TCTPs were overex-
pressed and purified using a Ni
2+-charged His-Bind column
according to manufacturer’s protocol (Novagen). The NH2-
terminal fusion proteins were separated by fast protein liquid
chromatography (FPLC) on a Mono Q HR 5/5 column
(Amersham Pharmacia Biotech) using a NaCl gradient. Buffer A
was 20 mM Tris-HCl, 1 mM EDTA, 50 mM NaCl, pH 7.4, and
Buffer B was 20 mM Tris-HCl, 1 mM EDTA, 1 M NaCl, pH 7.4.
A linear gradient from 0% to 15% Buffer B was run over 5 column
volumes and it was followed by a linear gradient from 15% to 50%
Buffer B over 25 column volumes to elute the TCTPs. Each eluted
fraction was desalted and transferred into PBS using PD-10
column (Amersham Pharmacia Biotech). Final proteins were
detected LPS contaminations by the Limulus Amebocyte lysate
(LAL) assay (Cambrex). The LAL assay showed that LPS
contaminations ranged from 1 to 100 pg/mg protein. Because it
had been known that BEAS-2B cells were relatively insensitive to
LPS [12], proteins purified using FPLC were used in cytokine
assays without further purification. The purity of the proteins was
85–98%. For T cells and sensitization and challenge of mice
airway, proteins were additionally purified with EndoTrap
(Cambrex).
Measurement of IL-8 and GM-CSF
Human bronchial epithelial cells, BEAS-2B (ATCC), were
maintained in bronchial epithelial growth medium (BEGM,
Clonetics). When BEAS-2B cells became 80% confluent, they
were passaged in 48-well culture plates, incubated for 20–24 h in
BEGM, washing twice with 1% penicillin-streptomycin/bronchial
epithelial basal medium (BEBM), and then incubated for the
indicated time with 1–10 mm/ml of proteins or without protein
(negative control, NC) in 1% penicillin-streptomycin/BEBM. IL-8
and GM-CSF secreted into media were measured by ELISA using
a commercial kit (PIERCE).
Measurement of IL-2
Human jurkat T cells (ATCC) were maintained in RPMI 1640
containing, 10 mM HEPES, 2 mM L-Glutamine, 1 mM sodium
pyruvate, 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10%
heat-inactivated FBS, 1% penicillin-streptomycin. Cells were
preincubated at 10
6 cells/well for 4 h with TCTPs in growth
medium or with medium alone (NC), and then stimulated with
10 mm/ml PMA and 25–500 mm/ml ionomycin for 20 h. IL-2 in
supernatant was measured using ELISA kit (PIERCE).
In vitro activation and differentiation of TH cells
CD4
+ TH cells were isolated from the draining lymph node of
the C57BL6 mice using mouse CD4 microbeads according to the
manufacturer’s instruction (Miltenyi Biotec). Cells were stimulated
with anti-CD3 (1 mg/ml) and anti-CD28 (1 mg/ml) antibodies (BD
Pharmingen) for 48 h, or restimulated with PMA (10 mm/ml) and
ionomycin (1 mM) at 72 h. For TH2 cell differentiation, cells were
co-stimulated with IL-4 (10 mm/ml) and anti-IFN-c Ab (5 mg/ml)
at day 1. Cells were induced to differentiate for additional 5 days
and re-stimulated with anti-CD3 for 24 h. CD4
+ TH cells were
incubated with RrTCTP or Del-N11TCTP accord with TCR
stimulation. Supernatants were harvested at 48 h or at 24 h after
secondary PMA/ionomycin or anti-CD3 stimulation. Superna-
tants were incubated with capturing antibodies specific for IL-2,
IL-4, or IFN-c, and subsequently biotinylated anti-cytokine
antibodies as instructed (BD Pharmingen).
Intracellular cytokine staining
CD4
+ TH cells were stimulated with anti-CD3 and anti-CD28
antibodies in the presence of RrTCTP or Del-N11TCTP for 72 h
and additionally stimulated with PMA and ionomycin for 4 h.
Cells were treated with Monensin (Sigma-Aldrich) for 2 h before
harvest and subsequently incubated with phycoerythrin (PE)-
tagged anti-IL-2 Ab or allophycocyanin (APC)-conjugated IL-4
Ab. After washing the cells with PBS, cells were analyzed by FACS
Calibur and CellQuest program (BD Biosciences).
Development of airway inflammation and lung analyses
BALB/c mice were sensitized at days 0 and 14 (i.p.) with OVA,
RrTCTP or Del-N11TCTP. At day 28, the sensitized mice were
challenged with the same allergen (300 mg of OVA, 10 mgo f
RrTCTP or 10 mg of Del-N11TCTP) by intranasal administration
six times. At day 40, the mice were sacrificed and lungs and
bronchoalveolar lavage (BAL) fluids were collected and immune
cells were counted from the cytocentifuged cells. The supernatant
was used for IL-5 measurement by ELISA (PIERCE) and TCTP
detection by Western blotting. Lungs and rhinal tissues were fixed
in 4% paraformaldehyde. After dehydration in alcohol, tissues
were embedded in paraffin and cut into 5 mm thick sections.
Tissue sections were stained with PAS (Periodic Acid Schiff)
solution (Sigma-Aldrich). All animals were handled in strict
accordance with good animal practice as defined by the relevant
national and/or local animal welfare bodies, and all animal work
was approved by Ewha Womans University’s institutional animal
care and use committee.
Detection of the dimerized TCTP in sera of atopic and
atopic/asthmatic patients
All the subjects enrolled in this study gave written informed
consent, and the study protocol was approved by the Institutional
review board of Seoul National University Hospital (No. 0706-
040-211). The serum was precipitated with acetone/TCA,
denatured in 8 M urea/2% CHAPS, and analyzed on non-
reducing SDS-PAGE.
Confocal microscopy
BEAS-2B cells seeded on confocal dish (SPL) were blocked with
1% BSA/BEBM at RT for 10 min prior to 30 min incubation
with 5 mM of RrTCTP or Del-N11TCTP at 4uC. NC (without
protein), RrTCTP, Del-N11TCTP treated cells were washed and
labeled with rabbit anti-TCTP and rhodamine-conjugated goat
anti-rabbit antibody (Jackson ImmunoResearch) at 4uC. The cells
washed and then fixed in 3.7% formaldehyde/PBS for 15 min.
Confocal microscopy was performed using a Carl Zeiss Laser
Scanning Systems LSM 510. Z-stack images were taken at 0.1-mm
intervals, and the profile was analyzed.
Chemical Cross-linking of RrTCTPs
RrTCTP and Del-N35TCTP were irreversibly cross-linked by a
crosslinker for primary amines, DMS (dimethyl suberimidate?
2HCl, PIERCE), and two crosslinkers for sulfhydryl groups having
different lengths of spacer arms, BMOE (bis-maleimidoethane,
PIERCE), and BM(PEO)3 (1, 11-bismaleimidotriethylene glycol,
PIERCE). FPLC purified proteins were incubated with thirty-fold
molar excess of DMS for 30 min, five-fold molar excess of BMOE
for 2 h, or five-fold molar excess of BM(PEO)3 for 1 h at room
temperature. The reaction of DMS was stopped by adding Tris,
pH 7.5 at 50 mM final concentration; in all reactions, the excess
nonreacted crosslinkers was removed by vivaspin ultrafiltration
spin column (Vivascience). The resulting products were analyzed
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2B cells.
Overexpression and purification of HrTCTP and its
variants
pCEP4 expression vector (Invitrogen) was modified to facilitate
the construction of rabbit Fc fusion proteins by fusing sequences
encoding HrTCTP and its variants, Del-N11HrTCTP and Del-
N35HrTCTP, to the Fc region of rabbit IgG heavy chain. Human
IgG kappa chain leader sequence and the rabbit Fc were linked by
overlap extension PCR and the product was cloned in between the
HindIII and BamHI sites of the pCEP4 vector. Three cysteines in
the hinge region of the rabbit Fc region were converted to serine.
The TCTP and its variants were cloned in SfiI site between the
leader sequence and the rabbit Fc region. Full length human
TCTP gene was amplified by using a sense primer with SfiI site (
GGCCCAGGCGGCCATG ATT ATC TAC CGG GAC CTC
ATC AGC C) and an anti-sense primer with SfiI site
(GGCCGGCCTGGCC ACA TTT TTC CAT TTC TAA
ACC ATC CTT AAA GAA AAT CAT ATA TGG GGT CAC
ACC ATC C). This anti-sense primer was also used for amplifying
Del-N11HrTCTP and Del-N35HrTCTP genes. A sense primer
with SfiI site for Del-N11HRF gene was GGCCCAGGCGGCC
GAT GAG ATG TTC TCC GAC ATC TAC AAG ATC CGG
G and for Del-N35HRF gene was GGCCCAGGCGGCC ATG
GTC AGT AGG ACA GAA GGT AAC ATT G.
The constructs were transfected into HEK293T cells, and the
culture supernatant was harvested and clarified by centrifugation
at 4,000 rpm for 30 min and passed through a bottle-top filter
(Millipore Corporation) before application to a protein A-agarose
column (Repligen). After washing with binding buffer (PIERCE),
the binding proteins were eluted with 0.1 M glycine-HCl (pH 2.2).
The eluate was neutralized with 1 M Tris (pH 9.5). Protein
concentration was measured by BCA assay kit (PIERCE).
Statistical analysis
Results are expressed as means6SD. We evaluated the results
with a one-way ANOVA followed by multiple-comparison tests.
Differences were considered significant if p values were,0.05. The
Tukey’s HSD test is applied to all pairwise differences between
means, and Dunnett’s test was performed to compare each group
with the control.
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